Skip to main content
icon for Which vaccines will RFK end recommendations for?

Which vaccines will RFK end recommendations for?

icon for Which vaccines will RFK end recommendations for?

Which vaccines will RFK end recommendations for?

$1,399,277 Vol.

Dec 31, 2025
Polymarket

$1,399,277 Vol.

Polymarket

Polio

$22,600 Vol.

No

COVID-19

$602,048 Vol.

No

HPV

$316,492 Vol.

No

Influenza

$28,349 Vol.

No

Hepatitis B

$166,216 Vol.

No

Measles Mumps and Rubella

$263,573 Vol.

No

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,399,277
Tanggal Berakhir
Dec 31, 2025
Pasar Dibuka
Feb 21, 2025, 7:10 PM ET
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Hasil diajukan: No

Tidak ada sengketa

Hasil akhir: No

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
Volume
$1,399,277
Tanggal Berakhir
Dec 31, 2025
Pasar Dibuka
Feb 21, 2025, 7:10 PM ET
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

Hasil diajukan: No

Tidak ada sengketa

Hasil akhir: No

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Which vaccines will RFK end recommendations for?" adalah pasar prediksi di Polymarket dengan 6 hasil yang mungkin di mana trader membeli dan menjual saham berdasarkan apa yang mereka yakini akan terjadi. Hasil terdepan saat ini adalah "Polio" di 0%, diikuti oleh "COVID-19" di 0%. Harga mencerminkan probabilitas crowd-sourced real-time. Misalnya, saham yang dihargai 0¢ menyiratkan bahwa pasar secara kolektif memberikan peluang 0% pada hasil tersebut. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

Per hari ini, "Which vaccines will RFK end recommendations for?" telah menghasilkan $1.4 million dalam total volume trading sejak pasar diluncurkan pada Feb 22, 2025. Tingkat aktivitas trading ini mencerminkan keterlibatan kuat dari komunitas Polymarket dan membantu memastikan bahwa peluang saat ini diinformasikan oleh kumpulan besar peserta pasar. Kamu bisa melacak pergerakan harga langsung dan trading di hasil apa pun langsung di halaman ini.

Untuk trading di "Which vaccines will RFK end recommendations for?," jelajahi 6 hasil yang tersedia di halaman ini. Setiap hasil menampilkan harga saat ini yang mewakili probabilitas tersirat pasar. Untuk mengambil posisi, pilih hasil yang menurutmu paling mungkin, pilih "Ya" untuk mendukungnya atau "Tidak" untuk menentangnya, masukkan jumlahmu, dan klik "Trade." Jika hasil pilihanmu benar saat pasar diselesaikan, saham "Ya" kamu membayar $1 masing-masing. Jika salah, mereka membayar $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Ini adalah pasar yang sangat terbuka. Pemimpin saat ini untuk "Which vaccines will RFK end recommendations for?" adalah "Polio" di hanya 0%, dengan "COVID-19" mengejar ketat di 0%. Tanpa hasil yang menguasai mayoritas kuat, trader melihat ini sebagai sangat tidak pasti, yang bisa menghadirkan peluang trading unik. Peluang ini diperbarui secara real-time, jadi tandai halaman ini untuk menyaksikan bagaimana probabilitas berkembang.

Aturan resolusi untuk "Which vaccines will RFK end recommendations for?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.